| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Edoardo Parrella | Q53346741 |
| Vanessa Porrini | Q57443917 | ||
| P2093 | author name string | Marina Benarese | |
| Marina Pizzi | |||
| P2860 | cites work | Neonatal brain injury | Q80961596 |
| Mast cell stabilization limits hypoxic-ischemic brain damage in the immature rat | Q80971408 | ||
| Inflammatory gene profiling in the developing mouse brain after hypoxia-ischemia | Q81213230 | ||
| De novo synthesis of early growth response factor-1 is required for the full responsiveness of mast cells to produce TNF and IL-13 by IgE and antigen stimulation | Q81550790 | ||
| Postischemic administration of liposome-encapsulated luteolin prevents against ischemia-reperfusion injury in a rat middle cerebral artery occlusion model | Q83057250 | ||
| Clinico-pathological correlations in fatal ischemic stroke. An immunohistochemical study of human brain penumbra | Q83671582 | ||
| Ischemic insult induced apoptotic changes in PC12 cells: protection by trans resveratrol | Q84213136 | ||
| Resveratrol Pretreatment Decreases Ischemic Injury and Improves Neurological Function Via Sonic Hedgehog Signaling After Stroke in Rats | Q87028819 | ||
| Mast cells, neovascularization, and microhemorrhages are associated with saccular intracranial artery aneurysm wall remodeling | Q87518759 | ||
| Anti-inflammatory and antipruritic effects of luteolin from Perilla (P. frutescens L.) leaves | Q87973195 | ||
| Intracerebral Hemorrhage | Q89264284 | ||
| Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection | Q89289786 | ||
| Pharmacologic Prevention and Treatment of Neonatal Brain Injury | Q90210738 | ||
| Neuroprotective effects of a novel carnosine-hydrazide derivative on hippocampal CA1 damage after transient cerebral ischemia | Q90310277 | ||
| Targeting mast cell as a neuroprotective strategy | Q90565468 | ||
| Mast Cells in the Developing Brain Determine Adult Sexual Behavior | Q90859132 | ||
| MALAT1 Up-Regulator Polydatin Protects Brain Microvascular Integrity and Ameliorates Stroke Through C/EBPβ/MALAT1/CREB/PGC-1α/PPARγ Pathway | Q90874922 | ||
| Luteolin protects PC-12 cells from H2O2-induced injury by up-regulation of microRNA-21 | Q91893988 | ||
| Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT | Q21142738 | ||
| Mast cells in meningiomas and brain inflammation | Q21146660 | ||
| Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in rats | Q21203937 | ||
| New developments in mast cell biology | Q24634390 | ||
| Mast Cell: A Multi-Functional Master Cell | Q26771463 | ||
| The role of mast cells in the defence against pathogens | Q26825776 | ||
| Life after perinatal stroke | Q26861820 | ||
| Microglia and mast cells: two tracks on the road to neuroinflammation | Q26865144 | ||
| Molecular hydrogen as a preventive and therapeutic medical gas: initiation, development and potential of hydrogen medicine | Q26865444 | ||
| An update on the hyper-IgE syndromes | Q27021598 | ||
| Physiology and pathophysiology of carnosine. | Q27692648 | ||
| Systematic review and stratified meta-analysis of the efficacy of carnosine in animal models of ischemic stroke | Q28073784 | ||
| Pathobiology of ischaemic stroke: an integrated view | Q28141682 | ||
| Neuroprotection by flavonoids | Q28190414 | ||
| Stroke | Q28279570 | ||
| Effect of natural exogenous antioxidants on aging and on neurodegenerative diseases | Q28289119 | ||
| Kounis syndrome: A review article on epidemiology, diagnostic findings, management and complications of allergic acute coronary syndrome | Q30236034 | ||
| Kounis syndrome: an update on epidemiology, pathogenesis, diagnosis and therapeutic management | Q30251803 | ||
| Adenosine-induced vasoconstriction in vivo. Role of the mast cell and A3 adenosine receptor | Q30468304 | ||
| Brain mast cells link the immune system to anxiety-like behavior | Q30484650 | ||
| Inflammation and cerebral aneurysms | Q38170050 | ||
| Masitinib (AB1010), from canine tumor model to human clinical development: where we are? | Q38177027 | ||
| Stroke induces histamine accumulation and mast cell degranulation in the neonatal rat brain | Q46959330 | ||
| Carnosine is neuroprotective against permanent focal cerebral ischemia in mice | Q46966130 | ||
| Epigenetic and transcriptional control of mast cell responses | Q47119776 | ||
| Mast Cell Activation in Brain Injury, Stress, and Post-traumatic Stress Disorder and Alzheimer's Disease Pathogenesis | Q47148054 | ||
| Hydrogen Gas Inhalation Treatment in Acute Cerebral Infarction: A Randomized Controlled Clinical Study on Safety and Neuroprotection | Q47331946 | ||
| Stroke Incidence by Major Pathological Type and Ischemic Subtypes in the Auckland Regional Community Stroke Studies: Changes Between 2002 and 2011. | Q47355666 | ||
| Mast cells in the brain - Old cells, new target | Q47712486 | ||
| Carnosine suppresses oxygen-glucose deprivation/recovery-induced proliferation and migration of reactive astrocytes of rats in vitro | Q47769071 | ||
| Synergistic Association of Valproate and Resveratrol Reduces Brain Injury in Ischemic Stroke | Q47874264 | ||
| Combination Therapy with Low-Dose IVIG and a C1-esterase Inhibitor Ameliorates Brain Damage and Functional Deficits in Experimental Ischemic Stroke | Q47883886 | ||
| Molecular cloning and expression of the rat monocyte chemotactic protein-3 gene: a possible role in stroke | Q47920478 | ||
| Mast cell stabilization reduces hemorrhage formation and mortality after administration of thrombolytics in experimental ischemic stroke. | Q48118571 | ||
| Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals | Q48175944 | ||
| To Improve Translational Research in Subarachnoid Hemorrhage. | Q48268601 | ||
| The Role of Mast Cells in Intracerebral Hemorrhage | Q48268681 | ||
| Reduction of ischemic brain injury by administration of palmitoylethanolamide after transient middle cerebral artery occlusion in rats | Q48344436 | ||
| UPEI-400, a conjugate of lipoic acid and scopoletin, mediates neuroprotection in a rat model of ischemia/reperfusion | Q48382465 | ||
| Protective effect of luteolin in experimental ischemic stroke: upregulated SOD1, CAT, Bcl-2 and claudin-5, down-regulated MDA and Bax expression | Q48474348 | ||
| Thalamic mast cell activity is associated with sign-tracking behavior in rats | Q48556172 | ||
| PEA and luteolin synergistically reduce mast cell-mediated toxicity and elicit neuroprotection in cell-based models of brain ischemia | Q48620559 | ||
| Luteolin downregulates TLR4, TLR5, NF-κB and p-p38MAPK expression, upregulates the p-ERK expression, and protects rat brains against focal ischemia | Q48635755 | ||
| Mesenchymal stem cell-mediated immunomodulation in cell therapy of neurodegenerative diseases | Q48703346 | ||
| Cerebral mast cells mediate blood-brain barrier disruption in acute experimental ischemic stroke through perivascular gelatinase activation | Q48857637 | ||
| Resveratrol provides neuroprotection by inhibiting phosphodiesterases and regulating the cAMP/AMPK/SIRT1 pathway after stroke in rats | Q48906920 | ||
| Mast cells as sources of cytokines, chemokines, and growth factors. | Q50068970 | ||
| A comprehensive review of the health perspectives of resveratrol. | Q50087449 | ||
| Targeting mast cells in inflammatory diseases | Q38184283 | ||
| Tranilast: a review of its therapeutic applications | Q38275181 | ||
| An update on inflammation in the acute phase of intracerebral hemorrhage | Q38297832 | ||
| The crucial role of mast cells in blood-brain barrier alterations | Q38500852 | ||
| N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution | Q38521270 | ||
| Mast cell stabilisers | Q38541082 | ||
| The transcriptional program, functional heterogeneity, and clinical targeting of mast cells. | Q38642037 | ||
| Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation | Q38834682 | ||
| Pathophysiology of Birth Asphyxia | Q38927676 | ||
| Dnmt3a restrains mast cell inflammatory responses | Q38975300 | ||
| Immune responses in perinatal brain injury. | Q39014385 | ||
| Polydatin (PD) inhibits IgE-mediated passive cutaneous anaphylaxis in mice by stabilizing mast cells through modulating Ca²⁺ mobilization | Q39283265 | ||
| Mast cells in neuroinflammation and brain disorders. | Q39302923 | ||
| Blood-borne donor mast cell precursors migrate to mast cell-rich brain regions in the adult mouse | Q39604340 | ||
| TET2 Regulates Mast Cell Differentiation and Proliferation through Catalytic and Non-catalytic Activities | Q39781745 | ||
| Molecular hydrogen suppresses FcepsilonRI-mediated signal transduction and prevents degranulation of mast cells | Q39797577 | ||
| Specific and redundant roles for NFAT transcription factors in the expression of mast cell-derived cytokines. | Q40212619 | ||
| Effects of resveratrol on mast cell degranulation and tyrosine phosphorylation of the signaling components of the IgE receptor | Q40287898 | ||
| Scopoletin: an inducible nitric oxide synthesis inhibitory active constituent from Artemisia feddei | Q40939996 | ||
| Mast cell activation causes delayed neurodegeneration in mixed hippocampal cultures via the nitric oxide pathway | Q41221288 | ||
| Dependence of mast cell IgE-mediated cytokine production on nuclear factor-kappaB activity | Q41725156 | ||
| Hydrogen gas reduced acute hyperglycemia-enhanced hemorrhagic transformation in a focal ischemia rat model. | Q41860346 | ||
| Stroke: a global response is needed | Q42391655 | ||
| Mast cells migrate from blood to brain. | Q42482021 | ||
| Anti-Allergic Drugs Tranilast and Ketotifen Dose-Dependently Exert Mast Cell-Stabilizing Properties. | Q42699794 | ||
| Resveratrol Suppresses Cytokine Production Linked to FcεRI-MAPK Activation in IgE-Antigen Complex-Exposed Basophilic Mast Cells and Mice | Q42700018 | ||
| Resveratrol inhibits IgE-mediated basophilic mast cell degranulation and passive cutaneous anaphylaxis in mice | Q42712383 | ||
| Evidence that meningeal mast cells can worsen stroke pathology in mice. | Q42933266 | ||
| Neuroprotective effect of masitinib in rats with postischemic stroke | Q43091544 | ||
| Anti-Inflammatory, Anticholinesterase, and Antioxidant Potential of Scopoletin Isolated from Canarium patentinervium Miq. (Burseraceae Kunth). | Q43096683 | ||
| Contribution of mast cells to cerebral aneurysm formation | Q43119892 | ||
| Carnosine protects against permanent cerebral ischemia in histidine decarboxylase knockout mice by reducing glutamate excitotoxicity | Q43204013 | ||
| Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window. | Q43620009 | ||
| Deleterious effects of IL-9-activated mast cells and neuroprotection by antihistamine drugs in the developing mouse brain | Q43690545 | ||
| Luteolin inhibits mast cell-mediated allergic inflammation | Q43763709 | ||
| IVIG activates FcγRIIB-SHIP1-PIP3 Pathway to stabilize mast cells and suppress inflammation after ICH in mice | Q43805225 | ||
| In vitro inhibition of human conjunctival mast-cell degranulation by ketotifen | Q44369559 | ||
| Effect of cerebral ischemia on brain mast cells in rats | Q45015082 | ||
| Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry. | Q45917332 | ||
| Mast cells are early responders after hypoxia-ischemia in immature rat brain. | Q45972130 | ||
| Protective Effect of Mesenchymal Stem Cells Against the Development of Intracranial Aneurysm Rupture in Mice. | Q46035036 | ||
| Neuroprotective effects of orientin on oxygen-glucose deprivation/reperfusion-induced cell injury in primary culture of rat cortical neurons | Q46273997 | ||
| Insights Into the Neuroinflammatory Responses After Neonatal Hypoxia-Ischemia | Q46324062 | ||
| Effect of oxygen-glucose deprivation on degranulation and histamine release of mast cells | Q46679059 | ||
| Inhibitory effects of emedastine difumarate on histamine release. | Q46848538 | ||
| Carnosine attenuates mast cell degranulation and histamine release induced by oxygen-glucose deprivation | Q46862064 | ||
| Evolution of intracerebral hemorrhage after intravenous tPA: reversal of harmful effects with mast cell stabilization | Q30563965 | ||
| Different activation signals induce distinct mast cell degranulation strategies | Q30827625 | ||
| Perinatal arterial ischemic stroke: presentation, risk factors, evaluation, and outcome | Q30872844 | ||
| Future directions of acute ischaemic stroke therapy | Q30970322 | ||
| Cerebral mast cells regulate early ischemic brain swelling and neutrophil accumulation | Q33223356 | ||
| Mast cell blocking reduces brain edema and hematoma volume and improves outcome after experimental intracerebral hemorrhage | Q33254882 | ||
| Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor | Q33335777 | ||
| Influence of Ketotifen, Cromolyn Sodium, and Compound 48/80 on the survival rates after intestinal ischemia reperfusion injury in rats | Q33371093 | ||
| Intracerebral haemorrhage | Q33442365 | ||
| Mast cells as early responders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage | Q34093771 | ||
| Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain | Q34107477 | ||
| 4. IgE, mast cells, basophils, and eosinophils | Q34178190 | ||
| Stroke in newborn infants | Q34300601 | ||
| Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide | Q34309026 | ||
| The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons | Q34380089 | ||
| Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosis. | Q34384728 | ||
| Mast cell function: a new vision of an old cell | Q34430917 | ||
| Neuroprotection for ischaemic stroke: current status and challenges. | Q34437248 | ||
| Resveratrol neuroprotection in stroke and traumatic CNS injury | Q34489690 | ||
| Use of scopoletin to inhibit the production of inflammatory cytokines through inhibition of the IkappaB/NF-kappaB signal cascade in the human mast cell line HMC-1. | Q34572637 | ||
| Differential neuroprotective effects of carnosine, anserine, and N-acetyl carnosine against permanent focal ischemia | Q34593008 | ||
| Immunologic and therapeutic aspects of ketotifen | Q34695370 | ||
| Mast cells and neuroinflammation | Q34810678 | ||
| Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century | Q35172345 | ||
| Hypoxic Ischemic Encephalopathy: Pathophysiology and Experimental Treatments | Q35209809 | ||
| Mast cells promote blood brain barrier breakdown and neutrophil infiltration in a mouse model of focal cerebral ischemia | Q35572874 | ||
| Depression, strokes and dementia: new biological insights into an unfortunate pathway | Q35636066 | ||
| Mast-cell responses to pathogens. | Q35906088 | ||
| Mast cells in the development of adaptive immune responses | Q36015885 | ||
| The transcription factor Zeb2 regulates signaling in mast cells | Q36016557 | ||
| Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice | Q36025276 | ||
| Mast cells as "tunable" effector and immunoregulatory cells: recent advances. | Q36072458 | ||
| Regulation of mast cell responses in health and disease | Q36092456 | ||
| Biology of intracranial aneurysms: role of inflammation | Q36211346 | ||
| Resveratrol efficiently improves pulmonary function via stabilizing mast cells in a rat intestinal injury model. | Q50877016 | ||
| Cerebral vasospasm: presence of mast cells in human cerebral arteries after aneurysm rupture | Q50938999 | ||
| Tryptase-catalyzed core histone truncation: A novel epigenetic regulatory mechanism in mast cells. | Q51177448 | ||
| Spontaneous subarachnoid haemorrhage. | Q52121177 | ||
| Resveratrol improves delayed r-tPA treatment outcome by reducing MMPs. | Q52148119 | ||
| An Inflammation-Centric View of Neurological Disease: Beyond the Neuron. | Q52331711 | ||
| Luteolin-7-O-glucoside suppresses leukotriene C(4) production and degranulation by inhibiting the phosphorylation of mitogen activated protein kinases and phospholipase Cγ1 in activated mouse bone marrow-derived mast cells. | Q54577692 | ||
| c-Fos as a regulator of degranulation and cytokine production in FcepsilonRI-activated mast cells. | Q54707181 | ||
| Identification and functional analysis of differentially expressed genes associated with cerebral ischemia/reperfusion injury through bioinformatics methods | Q57173176 | ||
| Stroke | Q57312974 | ||
| Intracerebral haemorrhage: current approaches to acute management | Q57482499 | ||
| Current practice and future directions in the diagnosis and acute treatment of ischaemic stroke | Q57482501 | ||
| Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke | Q58086102 | ||
| The protective mechanisms of polydatin in cerebral ischemia | Q58591443 | ||
| Oleoylethanolamide and Palmitoylethanolamide Protect Cultured Cortical Neurons Against Hypoxia | Q58718644 | ||
| Palmitoylethanolamide prevents neuroinflammation, reduces astrogliosis and preserves recognition and spatial memory following induction of neonatal anoxia-ischemia | Q60714197 | ||
| Resveratrol Suppresses Gut-Derived NLRP3 Inflammasome Partly through Stabilizing Mast Cells in a Rat Model | Q60944362 | ||
| Meningeal Mast Cells as Key Effectors of Stroke Pathology | Q64079691 | ||
| Mast Cells in Stress, Pain, Blood-Brain Barrier, Neuroinflammation and Alzheimer's Disease | Q64228531 | ||
| A Polyphenol-Enriched Supplement Exerts Potent Epigenetic-Protective Activity in a Cell-Based Model of Brain Ischemia | Q64256235 | ||
| Mast cell degranulation and its inhibition by an anti-allergic agent tranilast. An electron microscopic study | Q69037977 | ||
| Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques | Q77544889 | ||
| Effects of taurine, carnosine, and casomorphine on functional activity of rat peritoneal mast cells | Q79315388 | ||
| Mast cells promote atherosclerosis by releasing proinflammatory cytokines | Q80422792 | ||
| The early growth response factor-1 is involved in stem cell factor (SCF)-induced interleukin 13 production by mast cells, but is dispensable for SCF-dependent mast cell growth | Q80446909 | ||
| A basic study on molecular hydrogen (H2) inhalation in acute cerebral ischemia patients for safety check with physiological parameters and measurement of blood H2 level | Q36278482 | ||
| The role of inflammation in perinatal brain injury | Q36331560 | ||
| Macrophage imbalance (M1 vs. M2) and upregulation of mast cells in wall of ruptured human cerebral aneurysms: preliminary results | Q36369742 | ||
| Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man. | Q36484546 | ||
| Macrophage imaging within human cerebral aneurysms wall using ferumoxytol-enhanced MRI: a pilot study | Q36570419 | ||
| Resveratrol preferentially inhibits IgE-dependent PGD2 biosynthesis but enhances TNF production from human skin mast cells | Q36609669 | ||
| Hydrogen inhalation ameliorated mast cell-mediated brain injury after intracerebral hemorrhage in mice | Q36778027 | ||
| Stroke injury, cognitive impairment and vascular dementia | Q36786383 | ||
| Mast cells in the promotion and limitation of chronic inflammation. | Q36819950 | ||
| CNS vasculitis and stroke as a complication of DOCK8 deficiency: a case report | Q36836976 | ||
| The multitasking mast cell: positive and negative roles in the progression of autoimmunity | Q36914685 | ||
| Safety of intravenous administration of hydrogen-enriched fluid in patients with acute cerebral ischemia: initial clinical studies | Q36959734 | ||
| Targeting ischemic brain injury with intravenous immunoglobulin | Q37030865 | ||
| Gender differences in stroke incidence and poststroke disability in the Framingham heart study | Q37178347 | ||
| Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke | Q37212005 | ||
| Critical role of mast cell chymase in mouse abdominal aortic aneurysm formation | Q37375537 | ||
| Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought | Q37418272 | ||
| Intravenous immunoglobulin protects neurons against amyloid beta-peptide toxicity and ischemic stroke by attenuating multiple cell death pathways | Q37487547 | ||
| Multiple action agents and the eye: do they really stabilize mast cells? | Q37571375 | ||
| A review on the vascular features of the hyperimmunoglobulin E syndrome | Q37632481 | ||
| Proteolytic histone modification by mast cell tryptase, a serglycin proteoglycan-dependent secretory granule protease | Q37635812 | ||
| Resveratrol post-treatment protects against neonatal brain injury after hypoxia-ischemia | Q37694778 | ||
| Acute pathophysiological processes after ischaemic and traumatic brain injury | Q37880984 | ||
| Ketotifen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders | Q37977366 | ||
| The SNARE Machinery in Mast Cell Secretion | Q38017191 | ||
| Intravenous immune globulin in autoimmune and inflammatory diseases | Q38061484 | ||
| Palmitoylethanolamide in homeostatic and traumatic central nervous system injuries | Q38080157 | ||
| New insights in mast cell modulation by palmitoylethanolamide | Q38080159 | ||
| The role of mast cells in neuroinflammation | Q38081099 | ||
| Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator | Q38118187 | ||
| Mast cells on the mind: new insights and opportunities | Q38120910 | ||
| Advances and challenges in treatment and prevention of ischemic stroke | Q38127644 | ||
| Mast cells, glia and neuroinflammation: partners in crime? | Q38137173 | ||
| The role of vascular remodeling and inflammation in the pathogenesis of intracranial aneurysms | Q38152151 | ||
| Inflammation in intracerebral hemorrhage: from mechanisms to clinical translation | Q38167572 | ||
| Links between allergy and cardiovascular or hemostatic system. | Q38169391 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P921 | main subject | mast cell | Q191989 |
| encephalitis | Q199615 | ||
| blood–brain barrier | Q221694 | ||
| Taking acetaminophen after smoking cannabis | Q979168 | ||
| P577 | publication date | 2019-05-10 | |
| P1433 | published in | Cells | Q27724621 |
| P1476 | title | The Role of Mast Cells in Stroke. | |
| P478 | volume | 8 |
Search more.